LU92135I2 - Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa - Google Patents

Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa

Info

Publication number
LU92135I2
LU92135I2 LU92135C LU92135C LU92135I2 LU 92135 I2 LU92135 I2 LU 92135I2 LU 92135 C LU92135 C LU 92135C LU 92135 C LU92135 C LU 92135C LU 92135 I2 LU92135 I2 LU 92135I2
Authority
LU
Luxembourg
Prior art keywords
serogroup
canine
caused
leptospira
interrogans
Prior art date
Application number
LU92135C
Other languages
English (en)
Other versions
LU92135I9 (fr
Original Assignee
Pah Usa 15 Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35657262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92135(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pah Usa 15 Llc filed Critical Pah Usa 15 Llc
Publication of LU92135I2 publication Critical patent/LU92135I2/fr
Publication of LU92135I9 publication Critical patent/LU92135I9/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/23Parvoviridae, e.g. feline panleukopenia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175Canine distemper virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/235Adenoviridae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
LU92135C 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa LU92135I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/959,757 US20050089533A1 (en) 2003-01-29 2004-10-06 Canine vaccines against Bordetella bronchiseptica

Publications (2)

Publication Number Publication Date
LU92135I2 true LU92135I2 (fr) 2013-03-18
LU92135I9 LU92135I9 (fr) 2019-01-04

Family

ID=35657262

Family Applications (2)

Application Number Title Priority Date Filing Date
LU92136C LU92136I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava
LU92135C LU92135I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU92136C LU92136I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava

Country Status (26)

Country Link
US (2) US20050089533A1 (fr)
EP (1) EP1799253B1 (fr)
JP (2) JP4163245B2 (fr)
KR (3) KR101226869B1 (fr)
CN (2) CN101791398A (fr)
AT (1) ATE524193T1 (fr)
AU (1) AU2005290921C1 (fr)
BR (1) BRPI0516253A (fr)
CA (1) CA2583689C (fr)
CY (1) CY1114897T1 (fr)
DK (1) DK1799253T3 (fr)
ES (1) ES2370750T3 (fr)
HK (1) HK1112839A1 (fr)
LU (2) LU92136I2 (fr)
ME (1) ME01306B (fr)
MX (1) MX2007004133A (fr)
NO (1) NO20071385L (fr)
NZ (3) NZ553867A (fr)
PL (1) PL1799253T3 (fr)
PT (1) PT1799253E (fr)
RS (1) RS52035B (fr)
RU (1) RU2400248C2 (fr)
SI (1) SI1799253T1 (fr)
UA (1) UA91197C2 (fr)
WO (1) WO2006038115A1 (fr)
ZA (1) ZA200702166B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
KR20080042174A (ko) * 2005-10-07 2008-05-14 화이자 프로덕츠 인코포레이티드 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
JPWO2008032796A1 (ja) * 2006-09-13 2010-01-28 日本全薬工業株式会社 新規イヌ用ワクチン
SG176451A1 (en) * 2006-11-03 2011-12-29 Schering Plough Ltd Canine lyme disease vaccine
KR101099883B1 (ko) * 2006-12-27 2011-12-28 화이자 프로덕츠 인코포레이티드 백신 투여 방법
AU2015255165A1 (en) * 2006-12-27 2015-11-26 Zoetis Services Llc Methods of vaccine administration
PL2134742T3 (pl) 2007-02-27 2012-10-31 Zoetis Services Llc Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt
US7878586B2 (en) * 2007-10-29 2011-02-01 The Boeing Company System and method for an anticipatory passenger cabin
NZ585877A (en) 2007-12-21 2012-06-29 Pfizer Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
EP2488634A4 (fr) 2009-10-14 2013-04-03 Univ Oklahoma State Isolement d'un virus apparenté au parvovirus canin de type 2 à partir d'un raton laveur
EP2623118A4 (fr) 2010-09-28 2014-05-07 Kyoritsu Seiyaku Corp Composition d'adjuvant mucosal
EP2670431A1 (fr) * 2011-02-04 2013-12-11 Zoetis LLC Compositions pour traiter un complexe de maladies respiratoires canines
JP5833145B2 (ja) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー 免疫原性bordetellabronchiseptica組成物
CN102343088B (zh) * 2011-10-14 2013-02-13 浙江诺倍威生物技术有限公司 一种犬传染性气管支气管炎二联活疫苗及其制备方法
EP2884996B1 (fr) * 2012-08-17 2020-01-08 Intervet International B.V. Composition immunogène de bactéries de leptospira mortes
AU2013304049B2 (en) * 2012-08-17 2017-05-25 Intervet International B.V. An immunogenic composition of killed Leptospira bacteria
US9314519B2 (en) * 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CZ307883B6 (cs) * 2013-01-29 2019-07-24 Bioveta, A.S. Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
KR101622554B1 (ko) 2014-07-16 2016-05-19 (주)양성그린바이오 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법
EP3909971A1 (fr) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Vaccin de bétail à cellules entières pour maladies respiratoires
CN117187118B (zh) * 2023-08-16 2024-07-23 华中农业大学 一株支气管败血波氏杆菌a1218及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
CA2158540A1 (fr) * 1993-03-31 1994-10-13 David A. Haake Proteine de membrane externe clonee provenant de leptospira
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
AUPO549497A0 (en) * 1997-03-07 1997-03-27 Agriculture Victoria Services Pty Ltd Novel bacterial pathogens
US6306623B1 (en) * 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
DE60222812T2 (de) * 2002-05-17 2008-08-28 Fundação Oswaldo Cruz (Fiocruz) In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen
ME00810B (fr) * 2002-08-26 2012-03-20 Zoetis Services Llc Vaccin contre les infections de l'appareil genital et du systeme respiratoire chez les bovins
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
PL378001A1 (pl) * 2003-01-29 2006-02-20 Pfizer Products Inc. Szczepionki przeciw Bordetella bronchiseptica dla psów
KR101099883B1 (ko) * 2006-12-27 2011-12-28 화이자 프로덕츠 인코포레이티드 백신 투여 방법

Also Published As

Publication number Publication date
KR20120031294A (ko) 2012-04-02
NZ591422A (en) 2012-09-28
CA2583689C (fr) 2013-06-11
CN101791398A (zh) 2010-08-04
NZ576898A (en) 2011-03-31
CN101035558A (zh) 2007-09-12
CN101035558B (zh) 2011-04-06
SI1799253T1 (sl) 2011-11-30
NZ553867A (en) 2010-10-29
NO20071385L (no) 2007-04-18
UA91197C2 (ru) 2010-07-12
RS52035B (en) 2012-04-30
RU2400248C2 (ru) 2010-09-27
CA2583689A1 (fr) 2006-04-13
ME01306B (me) 2013-12-20
PL1799253T3 (pl) 2012-01-31
MX2007004133A (es) 2007-06-15
RU2007112480A (ru) 2008-11-20
AU2005290921B2 (en) 2010-07-08
AU2005290921A1 (en) 2006-04-13
ATE524193T1 (de) 2011-09-15
ZA200702166B (en) 2008-11-26
LU92135I9 (fr) 2019-01-04
JP2008515873A (ja) 2008-05-15
HK1112839A1 (en) 2008-09-19
KR20080096610A (ko) 2008-10-30
US20080175860A1 (en) 2008-07-24
EP1799253A1 (fr) 2007-06-27
BRPI0516253A (pt) 2008-08-26
PT1799253E (pt) 2011-11-10
JP2008239627A (ja) 2008-10-09
CY1114897T1 (el) 2016-12-14
AU2005290921C1 (en) 2012-10-11
JP4163245B2 (ja) 2008-10-08
LU92136I9 (fr) 2019-01-04
DK1799253T3 (da) 2011-11-28
LU92136I2 (fr) 2013-03-18
WO2006038115A1 (fr) 2006-04-13
KR20070050499A (ko) 2007-05-15
EP1799253B1 (fr) 2011-09-14
ES2370750T3 (es) 2011-12-22
US20050089533A1 (en) 2005-04-28
KR101226869B1 (ko) 2013-01-25

Similar Documents

Publication Publication Date Title
LU92135I2 (fr) Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa
TW200505476A (en) Canine vaccines against bordetella bronchiseptica
HRP20050192B1 (hr) Cjepivo za infekcije dišnog i spolnog sustava kod goveda
AR064530A1 (es) Procedimientos para la administracion de vacunas
AR007864A1 (es) Formula de vacuna porcina, su utilizacion y kit de vacunacion que la contiene.
CA2565925A1 (fr) Vaccin pour parodontopathie
WO2004093904A3 (fr) Methodes pour prevenir les maladies genesiques des bovins
AR070675A1 (es) Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente
WO2008106393A3 (fr) Compositions immunogènes et procédés de traitement et de prévention d'infections chez les animaux
RU2006133328A (ru) Способ вакцинации против инфекции семенников bvdv
Gomes-Solecki et al. A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice
NZ595748A (en) Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
Gingerich et al. Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year
DK1185662T3 (da) DNA-vacciner til hunde
AR045152A1 (es) Vacunas virales mutantes
DOP2003000699A (es) Vacunas para enfermedades reproductoras del ganado
UA32966U (ru) Вакцина против лептоспироза животных поливалентная (вариант suis)